Sponsor Dossier
Galderma
Sponsor Dossier for Galderma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AKLIEF
- Brand: Benzac
- Brand: Cetaphil
- Brand: CLOBEX
- Brand: Daily
- Brand: Daylong
- Brand: DESOWEN
- Brand: DIFFERIN
- Device (sponsor): Restylane Skinboosters Vital Light Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Restylane Lyft Lidocane - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Restylane Refyne - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Restylane Skinboosters Vital Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Restylane Kysse - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Restylane Defyne - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Restylane Volyme - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Sculptra Poly-L-lactic acid - Dermal tissue reconstructive material, synthetic polymer
- Device (sponsor): Soap, skin, liquid
- Device (sponsor): Skin exfoliant, professional
- Device (sponsor): Spatula, <specify>
- Device (sponsor): Skin moisturizing/barrier dressing
- Device (sponsor): RESTYLANE CLASSYC LIDOCAINE - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Surgical procedure kit, general-purpose, single-use, medicated
- Device (sponsor): Spatula, <specify>
About
Galderma is an Australian Private Company with ABN 12 003 976 930, registered in New South Wales. The entity is active and registered for GST.
Portfolio
Galderma has 17 brands on the ARTG, of which 11 are indexable. Ten brands have Product Information on file. Four brands have PBAC outcomes on record and four brands have AusPARs on record. Notable brands include AKLIEF, Benzac, Cetaphil, CLOBEX, Daily, Daylong, DESOWEN, DIFFERIN, EPIDUO, LOCERYL, LUMEXIA and METVIX.
Therapeutic focus
— Dermatology: 14 brands — Oncology: 2 brands — Endocrinology: 1 brand
PBS footprint
Galderma has no PBS-listed brands in its portfolio.
Regulatory activity
The most recent PBAC outcome for Galderma was in July 2025, with four brands holding PBAC outcomes on record. The most recent AusPAR was published in January 2021, with four brands holding AusPARs on record.